AZN

209.48

1.91% 3.93

Pre-mercato: 212.65 3.17 +1.51%

Astrazeneca Plc (AZN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché AZN Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$205.55

Aprire:

$208.1

Volume 24 ore:

2.29M

Relative Volume:

0.38

Capitalizzazione di mercato:

$324.75B

Reddito:

$58.80B

Utile/perdita netta:

$10.24B

Rapporto P/E:

63.89

EPS:

3.2788

Flusso di cassa netto:

$8.98B

1 W Prestazione:

+8.31%

1M Prestazione:

+121.93%

6M Prestazione:

+164.60%

1 anno Prestazione:

+184.70%

Intervallo 1D:

$207.85

$211.27

Intervallo di 1 settimana:

$199.19

$211.27

Portata 52W:

$61.24

$211.27

Astrazeneca Plc Stock (AZN) Company Profile

Nome

Astrazeneca Plc

Settore

Healthcare (1115)

Industria

Drug Manufacturers - General (20)

Telefono

Indirizzo

Dipendente

94,300

Cinguettio

@AstraZeneca

Prossima data di guadagno

2026-02-10

Ultimi documenti SEC

AZN's Discussions on Twitter

Compare AZN vs LLY, JNJ, ABBV, NVS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AZN Astrazeneca Plc	209.48	318.66B	58.80B	10.24B	8.98B	3.2788
LLY Lilly Eli Co	1,036.05	981.09B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	243.33	586.69B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	232.86	409.15B	61.16B	4.20B	19.68B	2.3671
NVS Novartis Ag Adr	166.17	311.22B	54.72B	14.02B	15.32B	7.1855

Astrazeneca Plc Stock (AZN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-27	Iniziato	Citigroup	Buy
2025-10-27	Ripresa	Jefferies	Buy
2025-10-16	Downgrade	Deutsche Bank	Hold → Sell
2025-04-15	Iniziato	Exane BNP Paribas	Outperform
2025-02-13	Aggiornamento	UBS	Neutral → Buy
2025-02-12	Iniziato	Morgan Stanley	Overweight
2024-11-20	Aggiornamento	UBS	Sell → Neutral
2024-11-06	Aggiornamento	Deutsche Bank	Sell → Hold
2024-09-13	Downgrade	Deutsche Bank	Hold → Sell
2024-05-30	Iniziato	Goldman	Buy
2024-04-16	Aggiornamento	Deutsche Bank	Sell → Hold
2024-02-08	Downgrade	Deutsche Bank	Hold → Sell
2024-01-23	Iniziato	Morgan Stanley	Overweight
2024-01-16	Ripresa	UBS	Sell
2024-01-03	Downgrade	Jefferies	Buy → Hold
2023-12-18	Iniziato	HSBC Securities	Buy
2023-09-25	Aggiornamento	Jefferies	Hold → Buy
2023-07-14	Iniziato	HSBC Securities	Buy
2023-07-12	Aggiornamento	UBS	Neutral → Buy
2023-07-05	Downgrade	Deutsche Bank	Buy → Hold
2023-04-11	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-01-05	Iniziato	BMO Capital Markets	Outperform
2022-09-15	Downgrade	Credit Suisse	Outperform → Neutral
2022-09-07	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-08-29	Aggiornamento	Argus	Hold → Buy
2022-06-14	Downgrade	UBS	Buy → Neutral
2022-02-11	Aggiornamento	DZ Bank	Sell → Hold
2021-12-07	Downgrade	Jefferies	Buy → Hold
2021-08-12	Ripresa	JP Morgan	Overweight
2021-04-12	Downgrade	Argus	Buy → Hold
2021-03-16	Aggiornamento	Jefferies	Hold → Buy
2021-02-25	Aggiornamento	UBS	Neutral → Buy
2021-01-15	Iniziato	Deutsche Bank	Buy
2020-12-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-11-30	Aggiornamento	UBS	Sell → Neutral
2020-11-11	Aggiornamento	HSBC Securities	Reduce → Hold
2020-09-29	Iniziato	Berenberg	Buy
2019-11-22	Iniziato	SVB Leerink	Outperform
2019-10-25	Aggiornamento	Liberum	Hold → Buy
2019-04-02	Downgrade	UBS	Neutral → Sell
2019-02-05	Iniziato	Exane BNP Paribas	Outperform
2019-01-25	Aggiornamento	Shore Capital	Hold → Buy
2018-12-11	Ripresa	Jefferies	Hold
2018-10-09	Iniziato	Guggenheim	Buy
2018-08-16	Downgrade	Jefferies	Buy → Hold
2018-03-19	Aggiornamento	Jefferies	Hold → Buy
2018-02-06	Reiterato	Leerink Partners	Mkt Perform
2018-02-05	Reiterato	Bernstein	Outperform
2018-01-18	Reiterato	Leerink Partners	Mkt Perform
2017-12-29	Aggiornamento	JP Morgan	Neutral → Overweight
2017-10-16	Aggiornamento	Credit Suisse	Neutral → Outperform
2017-09-25	Aggiornamento	Exane BNP Paribas	Neutral → Outperform
2017-09-22	Aggiornamento	Bernstein	Mkt Perform → Outperform

Mostra tutto

Astrazeneca Plc Borsa (AZN) Ultime notizie

05:55 AM

Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider - GlobeNewswire Inc.

05:55 AM

Feb 17, 2026

Stock Watch: AstraZeneca’s Fourth-Quarter Results Are Solid, But Not Vintage - Citeline News & Insights

Feb 17, 2026

HighTower Advisors LLC Increases Stake in AstraZeneca PLC $AZN - MarketBeat

Feb 17, 2026

Risk Off: Can Safe Bulkers Inc lead its sector in growthPortfolio Performance Report & Capital Efficiency Focused Ideas - baoquankhu1.vn

Feb 17, 2026

Crestwood Advisors Group LLC Has $40.30 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat

Feb 17, 2026

Denali Advisors LLC Has $689,000 Stock Position in AstraZeneca PLC $AZN - MarketBeat

Feb 17, 2026

Below £151, here’s why AstraZeneca’s share price looks a steal to me under £228.62 after strong 2025 results - Fool UK

Feb 17, 2026

AstraZeneca (LON:AZN) Hits New 52-Week HighHere's Why - MarketBeat

Feb 17, 2026

Is It Too Late To Consider AstraZeneca (LSE:AZN) After Strong Multi‑Year Share Gains? - Yahoo Finance UK

Feb 17, 2026

Inside Biotech: AstraZeneca halts generic diabetes pill launch in patent battle with Pharmacor - Proactive Investors

Feb 17, 2026

Feb 16, 2026

Oddo BHF raises TP for AstraZeneca shares - marketscreener.com

Feb 16, 2026

Feb 15, 2026

AstraZeneca awards $3.4 million to US nonprofits to expand healthcare access - MSN

Feb 15, 2026

Krilogy Financial LLC Takes $731,000 Position in AstraZeneca PLC $AZN - MarketBeat

Feb 14, 2026

Cookson Peirce & Co. Inc. Invests $1.05 Million in AstraZeneca PLC $AZN - MarketBeat

Feb 14, 2026

Advisors Asset Management Inc. Acquires 8,453 Shares of AstraZeneca PLC $AZN - MarketBeat

Feb 14, 2026

Feb 13, 2026

Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory - Yahoo Finance

Feb 13, 2026

Shore Capital lowers AstraZeneca to 'hold' - Sharecast.com

Feb 13, 2026

Published on: 2026-02-13 16:14:39 - mfd.ru

Feb 13, 2026

AstraZeneca's (AZN) Breztri Aerosphere Shows Promising Results i - GuruFocus

Feb 13, 2026

AstraZeneca's BREZTRI Shows Significant Asthma Improvement in Phase III Trials - Intellectia AI

Feb 13, 2026

Caprock Group LLC Takes $3.10 Million Position in AstraZeneca PLC $AZN - MarketBeat

Feb 13, 2026

AstraZeneca Announces BrePREMIUM Trial Results - Intellectia AI

Feb 13, 2026

AstraZeneca Says Breztri Improves Lung Function, Reduces Attacks in Phase 3 Asthma Trials - marketscreener.com

Feb 13, 2026

AstraZeneca Earnings: Strong Finish to Year, and Busy Schedule of Data Readouts Ahead - Morningstar Canada

Feb 13, 2026

AstraZeneca - Britannica

Feb 13, 2026

AstraZeneca PLC (LON:AZN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance

Feb 13, 2026

Feb 12, 2026

What makes AstraZeneca (AZN) a strong growing company? - MSN

Feb 12, 2026

Market voices: Paramount-WBD bid, Holtec IPO, AstraZeneca - MSN

Feb 12, 2026

AstraZeneca's Portfolio and Pipeline Support Solid Long-Term Growth - Morningstar

Feb 12, 2026

6,649 Shares in AstraZeneca PLC $AZN Acquired by Westover Capital Advisors LLC - MarketBeat

Feb 12, 2026

Here’s What Lifted AstraZeneca PLC (AZN) in Q4 - Insider Monkey

Feb 12, 2026

Madison Asset Management LLC Trims Stock Holdings in AstraZeneca PLC $AZN - MarketBeat

Feb 12, 2026

Big Deal, Bigger Doubts: CSPC Slides After $18.5B Pact With AstraZeneca - Benzinga

Feb 12, 2026

Kangtai Drops Plan for China Vaccine JV With AstraZeneca - Citeline News & Insights

Feb 12, 2026

Feb 11, 2026